Adagene (Adagene) FCF Yield % : -24.30 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Adagene FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Adagene's Trailing 12-Month Free Cash Flow is $-28.54 Mil, and Market Cap is $117.46 Mil. Therefore, Adagene's FCF Yield % for today is -24.30%.

The historical rank and industry rank for Adagene's FCF Yield % or its related term are showing as below:

ADAG' s FCF Yield % Range Over the Past 10 Years
Min: -119.52 Med: -33.83 Max: -2.53
Current: -24.3

During the past 6 years, the highest FCF Yield % of Adagene was -2.53%. The lowest was -119.52%. And the median was -33.83%.

ADAG's FCF Yield % is ranked worse than
62.07% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs ADAG: -24.30

Adagene's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Adagene FCF Yield % Historical Data

The historical data trend for Adagene's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagene FCF Yield % Chart

Adagene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-13.03

-86.03

-33.49

Adagene Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Adagene's FCF Yield %

For the Biotechnology subindustry, Adagene's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adagene's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adagene's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Adagene's FCF Yield % falls into.

Adagene FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Adagene's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-28.54	/	85.20699438
	=	-33.49%

Adagene's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	2	/	85.20699438
	=	0.00%

Adagene FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Adagene FCF Yield % Related Terms

Thank you for viewing the detailed overview of Adagene's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagene (Adagene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (NAS:ADAG) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

978:Germany

Address

Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123

Website

https://www.adagene.com

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.